公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1997 | Amplification of GB virus-C/hepatitis G virus RNA with primers from different regions of the viral genome | JIA-HORNG KAO ; PEI-JER CHEN ; Chen W.; Hsiang S.C.; Lai M.Y.; DING-SHINN CHEN | Journal of Medical Virology | 50 | | |
2016 | Analysis of clinical outcomes in pediatric bacterial meningitis focusing on patients without cerebrospinal fluid pleocytosis | Lin, Wen-Li; Chi, Hsin; Huang, Fu-Yuan; Huang, Daniel Tsung-Ning; Chiu, Nan-Chang | Journal of Microbiology Immunology and Infection | 17 | 17 | |
2023 | Androgen Enhances Aflatoxin-induced Genotoxicity and Inflammation to Liver Cancer in Male Hepatitis B Patients | Wang, Sheng Han; Shiou-Hwei Yeh ; PEI-JER CHEN | Cellular and Molecular Gastroenterology and Hepatology | 1 | 1 | |
2012 | Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis | Chen, Po-Jen; Shiou-Hwei Yeh ; Liu W.-H.; Lin C.-C.; Huang H.-C.; CHI-LING CHEN ; DING-SHINN CHEN ; PEI-JER CHEN | Hepatology | 90 | 92 | |
2002 | Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women | MING-WHEI YU ; Yang Y.-C.; Yang S.-Y.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; PEI-JER CHEN ; Lin S.-C.; Chen C.-J. | Hepatology | 27 | 22 | |
2022 | Androgen receptor functions in pericentral hepatocytes to decrease gluconeogenesis and avoid hyperglycemia and obesity in male mice | Chen, Kai Wei; Chen, Yu Shan; PEI-JER CHEN ; Shiou-Hwei Yeh | Metabolism: Clinical and Experimental | 3 | 0 | |
2014 | Anti-viral treatment and cancer control | WEI-LIANG SHIH ; CHI-TAI FANG ; PEI-JER CHEN | Recent Results in Cancer Research | 11 | 0 | |
2022 | Antiangiogenesis May Not Be a Universal Booster of EGFR Tyrosine Kinase Inhibitors | Wu, Tsung-Che; CHIA-CHI LIN | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2 | | |
2013 | Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: Current genotyping of EV71 does not reflect their antigenicity | Chen Y.; Li C.; He D.; Cheng T.; Ge S.; Shih J.W.K.; Zhao Q.; PEI-JER CHEN ; Zhang J.; Xia N. | Vaccine | 43 | 38 | |
2016 | Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results from the phase Ib KEYNOTE-012 expansion cohort | Chow L.Q.M.; Haddad R.; Gupta S.; Mahipal A.; Mehra R.; Tahara M.; Berger R.; Eder J.P.; Burtness B.; Lee S.-H.; Keam B.; Kang H.; Muro K.; Weiss J.; Geva R.; CHIA-CHI LIN ; Chung H.C.; Meister A.; Dolled-Filhart M.; Pathiraja K.; Cheng J.D.; Seiwert T.Y. | Journal of Clinical Oncology | 663 | 141 | |
2013 | Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence [2] | Yeh Y.-C.; PEI-JER CHEN ; Lai M.-S. | JAMA - Journal of the American Medical Association | 1 | 0 | |
2022 | APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis | You H.; Ma X.; Efe C.; Wang G.; Jeong S.-H.; Abe K.; Duan W.; Chen S.; Kong Y.; Zhang D.; Wei L.; Wang F.-S.; Lin H.-C.; Yang J.M.; Tanwandee T.; Gani R.A.; Payawal D.A.; Sharma B.C.; Hou J.; Yokosuka O.; Dokmeci A.K.; Crawford D.; JIA-HORNG KAO ; Piratvisuth T.; Suh D.J.; Lesmana L.A.; Sollano J.; Lau G.; Sarin S.K.; Omata M.; Tanaka A.; Jia J. | Hepatology International | 35 | 19 | |
2019 | APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment? | Kanda T.; Lau G.K.K.; Wei L.; Moriyama M.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Dokmeci A.K.; Mamun-Al-Mahtab, McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Yokosuka O.; Sarin S.K.; Omata M. | Hepatology International | 31 | 27 | |
2012 | APASL consensus statements and management algorithms for hepatitis C virus infection | Omata M.; Kanda T.; Yu M.-L.; Yokosuka O.; Lim S.-G.; Jafri W.; Tateishi R.; Hamid S.S.; Chuang W.-L.; Chutaputti A.; Wei L.; Sollano J.; Sarin S.K.; JIA-HORNG KAO ; McCaughan G.W. | Hepatology International | 143 | 132 | |
2016 | APASL consensus statements and recommendation on treatment of hepatitis C | Omata M.; Kanda T.; Wei L.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Dokmeci A.K.; Mamun-Al-Mahtab, McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Yokosuka O.; Lau G.K.K.; Sarin S.K. | Hepatology International | 185 | 167 | |
2016 | APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing | Omata M.; Kanda T.; Wei L.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Dokmeci A.K.; Al-Mahtab M.; McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Yokosuka O.; Lau G.K.K.; Sarin S.K. | Hepatology International | 72 | 70 | |
2021 | APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients | JIA-HORNG KAO ; Jeng W.-J.; Ning Q.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Ueno Y.; Yuen M.-F. | Hepatology International | 39 | 28 | |
2019 | APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation | Kanda T.; Lau G.K.K.; Wei L.; Moriyama M.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Kadir Dokmeci A.; Mamun-Al-Mahtab, McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Ooka Y.; Yokosuka O.; Sarin S.K.; Omata M. | Hepatology International | 67 | 63 | |
2001 | APM1/ADIPOQ GENE 在X症候群及粥狀動脈硬化之角色之研究 | 楊偉勛 | | | | |
2002 | ApM1/AdipoQ gene在胰島素抗拒與分泌之角色 | 楊偉勛 | | | | |